207 related articles for article (PubMed ID: 35606020)
21. Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy.
Yan RN; Cai TT; Jiang LL; Jing T; Cai L; Xie XJ; Su XF; Xu L; He K; Cheng L; Cheng C; Liu BL; Hu Y; Ma JH
Front Endocrinol (Lausanne); 2022; 13():832102. PubMed ID: 35222287
[TBL] [Abstract][Full Text] [Related]
22. Effects of unrestricted access to flash glucose monitoring in type 1 diabetes.
Hansen KW
Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00125. PubMed ID: 32704551
[TBL] [Abstract][Full Text] [Related]
23. Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture.
Luzi L; Carruba M; Crialesi R; Da Empoli S; Dagani R; Lovati E; Nicolucci A; Berra CC; Cipponeri E; Vaccaro K; Lenzi A
Acta Diabetol; 2021 Jul; 58(7):919-927. PubMed ID: 33740123
[TBL] [Abstract][Full Text] [Related]
24. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.
Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N
Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900
[TBL] [Abstract][Full Text] [Related]
25. The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies.
Han Y; Chen Y; Sun C; Zhou Z
Front Endocrinol (Lausanne); 2022; 13():1069559. PubMed ID: 36531473
[TBL] [Abstract][Full Text] [Related]
26. Improved glycemic control after the use of flash glucose monitoring accompanied by improved treatment satisfaction in patients with non-insulin-treated type 2 diabetes: A post-hoc analysis of a randomized controlled trial.
Hayase A; Onoue T; Kobayashi T; Wada E; Handa T; Kinoshita T; Yamagami A; Yasuda Y; Iwama S; Kawaguchi Y; Miyata T; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
Prim Care Diabetes; 2023 Dec; 17(6):575-580. PubMed ID: 37821263
[TBL] [Abstract][Full Text] [Related]
27. Type 1 diabetes and COVID-19: The "lockdown effect".
Aragona M; Rodia C; Bertolotto A; Campi F; Coppelli A; Giannarelli R; Bianchi C; Dardano A; Del Prato S
Diabetes Res Clin Pract; 2020 Dec; 170():108468. PubMed ID: 32987040
[TBL] [Abstract][Full Text] [Related]
28. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M
Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807
[TBL] [Abstract][Full Text] [Related]
29. Impact of COVID-19 Lockdown on the Metabolic Control Parameters in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Wafa IA; Pratama NR; Sofia NF; Anastasia ES; Konstantin T; Wijaya MA; Wiyono MR; Djuari L; Novida H
Diabetes Metab J; 2022 Mar; 46(2):260-272. PubMed ID: 35255551
[TBL] [Abstract][Full Text] [Related]
30. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA
BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807
[TBL] [Abstract][Full Text] [Related]
31. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5).
Lameijer A; Fokkert MJ; Edens MA; Slingerland RJ; Bilo HJG; van Dijk PR
J Clin Transl Endocrinol; 2020 Dec; 22():100237. PubMed ID: 33102135
[TBL] [Abstract][Full Text] [Related]
32. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
33. Weight gain in type 1 diabetes during the SARS-CoV-2 pandemic. Does lockdown affect the metabolic control of pediatric patients?
Zubkiewicz-Kucharska A; Wikiera B; Noczyńska A
Front Endocrinol (Lausanne); 2022; 13():991269. PubMed ID: 36313778
[TBL] [Abstract][Full Text] [Related]
34. Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years.
Tajdar D; Lühmann D; Walther L; Bittner L; Scherer M; Schäfer I
Diabetes Ther; 2024 Jun; 15(6):1375-1388. PubMed ID: 38642263
[TBL] [Abstract][Full Text] [Related]
35. The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes.
Heald AH; Stedman M; Horne L; Rea R; Whyte M; Gibson JM; Anderson SG; Ollier W
Diabet Med; 2022 Apr; 39(4):e14774. PubMed ID: 34936128
[TBL] [Abstract][Full Text] [Related]
36. The impact of COVID-19 lockdown on glycaemic control in young adults with type 1 diabetes mellitus.
Lockhart M; Green D; Smith D
Ir J Med Sci; 2023 Apr; 192(2):671-673. PubMed ID: 35701647
[TBL] [Abstract][Full Text] [Related]
37. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
[TBL] [Abstract][Full Text] [Related]
38. Effect of COVID-19 vaccine on blood glucose metrics in Arabic people with type 1 diabetes.
Al-Ozairi E; Irshad M; Taghadom E; Varghese A; Sojan L; Alkandari J
Front Endocrinol (Lausanne); 2023; 14():1120384. PubMed ID: 37020598
[TBL] [Abstract][Full Text] [Related]
39. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial.
Williams DM; Parsons SN; Dunseath GJ; Stephens JW; Luzio SD; Owens DR
Diabetes Metab Syndr; 2020; 14(2):101-106. PubMed ID: 31995784
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance Study.
O'Malley G; Ebekozien O; Desimone M; Pinnaro CT; Roberts A; Polsky S; Noor N; Aleppo G; Basina M; Tansey M; Steenkamp D; Vendrame F; Lorincz I; Mathias P; Agarwal S; Golden L; Hirsch IB; Levy CJ
J Clin Endocrinol Metab; 2021 Jan; 106(2):e936-e942. PubMed ID: 33165563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
